LDS/Medical Tests/Hepatitis B Core Antibody, IgG

Hepatitis B Core Antibody, IgG

Hepatitis B infection is caused by the Hepatitis B Virus. Hepatitis B virus is spread by contact with contaminated blood and body fluids. Chronic infection with Hepatitis B virus results in damage to the liver, ultimately resulting in liver disease including cirrhosis and/or liver cancer. The body’s immune system is responsible for the liver tissue damage because it destroys the liver cells containing the virus. Consumption of alcohol during infection with Hepatitis B virus is discouraged as it can increase the damage to the liver. Hepatitis B virus is prevented by cautious and safe handling of blood or body fluids, vaccination and refraining from activities known to be associated with risk of infection. Serology testing to detect hepatitis B surface antigen is the standard for diagnosing the disease. Hepatitis B surface antigen is produced by the virus itself and is used to detect a current infection of Hepatitis B. Antibody to Hepatitis B surface antigen is produced by the hepatitis B vaccine and can be tested for. Hepatitis Be Antigen and hepatitis Be antibody are tested in cases of chronic hepatitis B infections. Hepatitis Be antigen is present when the virus is actively replicating. Absence of HBe antigen and the presence of Anti-HBe indicate successful treatment.

Hepatitis B core antibody is the most commonly detected antibody in the disease. Total Anti-HBc antibody testing includes IgG and and IgM to HBc antigen. Total Anti-HBc will be positive indefinitely, whereas IgM is usually positive for 3 to 6 months after acute viral infection. HBc assays should not be used to test for acute Hepatitis B virus infection.

  • Diagnosis of hepatitis B virus infection (acute or chronic conditions)
  • Determining progress of disease in HBV infected patients
  • Aid in the differentiation of a hepatitis of unknown origin

Positive in:

  • Current hepatitis B infection
  • Hepatitis B carriers
  • Past hepatitis B infection

Negative (Non-reactive)
 

 

Enzyme immunoassay, Chemiluminescent immunoassay.

Serum (SST) or Plasma EDTA (Lavender) or Plasma Heparin. 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
HBV DNA by PCR (quantitative), HBsAg, HBeAg, Anti-HBe, HAV Antibody, HCV antibody, Liver panel, Acute Hepatitis Profile, Lactate Dehydrogenase, Liver biopsy.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Viral Hepat. 2011 Oct;18(10):721-9. [PMID: 21914087]
  • Clin Liver Dis. 2004;8:267. [PMID: 15481340]
  • Gastroenterol Clin Biol. 2008 Jan;32(1 Pt 2):S56-63. [PMID: 18662611]
  • N Engl J Med. 2004 Mar 11;350(11):1118-29. [PMID: 15014185]
  • Stevens, CD. Clinical Immunology & Serology A Laboratory Perspective 3rd edition. Philadelphia: F.A. Davis Company (2010).
  • Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).